arrow
Back
J

Jan H.M. Schellens

Department of Clinical Pharmacology

111H-index
1.2KPaper Count
5.9WCitation Count
Published Papers 349
Publication Date
Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors
err2025-05-14
err0
errOAAI
errDaphne W. M. Voogd; Merel J. J. Lucassen; Ruud van der Noll; Sybrand W. J. Zielhuis; David Boss; Jos H. Beijnen; Hilde Rosing; Matthijs Tibben; Alwin D. R. Huitema; Jan H. M. Schellens; Neeltje Steeghs
errShare
errSave
Dose-individualisation of fluoropyrimidines in DPYD wild-type patients: Final results from the Alpe2U study
err2024-09-01
err1
PREAI
errHeersche, N.; Knikman, J. E.; De With, M.; Lopez-Yurda, M.; Baars, A.; Creemers, G-J.; Droogendijk, H.; Fiets, E.; Deenen, M.; Van Schaik, R.; van den Bosch, B.; Oomen-de Hoop, E.; Rosing, H.; Swen, J.; Gelderblom, H.; Schellens, J. H. M.; Beijnen, J. H.; Mathijssen, R. H.; Guchelaar, H-J.; Cats, A.
errShare
errSave
Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis
err2024-01-15
err8
PREAI
errLe Teuff, Gwenael; Cozic, Nathalie; Boyer, Jean-Christophe; Boige, Valerie; Diasio, Robert B.; Taieb, Julien; Meulendijks, Didier; Palles, Claire; Schwab, Matthias; Deenen, Maarten; Largiader, Carlo R.; Marinaki, Anthony; Jennings, Barbara A.; Wettergren, Yvonne; Di Paolo, Antonello; Gross, Eva; Budai, Barna; Ackland, Stephen P.; van Kuilenburg, Andre B. P.; Mcleod, Howard L.; Milano, Gerard; Thomas, Fabienne; Loriot, Marie-Anne; Kerr, David; Schellens, Jan H. M.; Laurent-Puig, Pierre; Shi, Qian; Pignon, Jean-Pierre; Etienne-Grimaldi, Marie-Christine
errShare
errSave
A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens
err2023-11-29
err1
errOAAI
errKnikman, Jonathan E.; Lopez-Yurda, Marta; Meulendijks, Didier; Deenen, Maarten J.; Schellens, Jan H. M.; Beijnen, Jos; Cats, Annemieke; Guchelaar, Henk-Jan
errShare
errSave
Tumor-agnostic efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: ROAR basket study
err2023-04-14
err0
PREAI
errSubbiah, Vivek; Kreitman, Robert J.; Wainberg, Zev A.; Gazzah, Anas; Lassen, Ulrik; Stein, Alexander; Wen, Patrick Y.; Dietrich, Sascha; Jonge, Maja J. A.; Blay, Jean-Yves; Italiano, Antoine; Yonemori, Kan; Cho, Daniel C.; de Vos, Filip Y. F. L.; Moreau, Philippe; Fernandez, Elena Elez; Schellens, Jan H.; Zielinski, Christoph C.; Redhu, Suman; Passos, Vanessa Q.; Ilankumaran, Palanichamy; Bang, Yung-Jue
errShare
errSave
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
err2023-04-14
err95
errOAAI
errSubbiah, Vivek; Kreitman, Robert J.; Wainberg, Zev A.; Gazzah, Anas; Lassen, Ulrik; Stein, Alexander; Wen, Patrick Y.; Dietrich, Sascha; de Jonge, Maja J. A.; Blay, Jean-Yves; Italiano, Antoine; Yonemori, Kan; Cho, Daniel C.; de Vos, Filip Y. F. L.; Moreau, Philippe; Fernandez, Elena Elez; Schellens, Jan H. M.; Zielinski, Christoph C.; Redhu, Suman; Boran, Aislyn; Passos, Vanessa Q.; Ilankumaran, Palanichamy; Bang, Yung-Jue
errShare
errSave
Response to Plasma Uracil as a DPD Phenotyping Test: Pre-analytical Handling Matters
err2022-11-09
err0
PREAI
errde With, Mirjam; Knikman, Jonathan; Schellens, Jan H. M.; Gelderblom, Hans; Cats, Annemieke; Guchelaar, Henk-Jan; Mathijssen, Ron H. J.; Swen, Jesse J.; Meulendijks, Didier
errShare
errSave
Fluoropyrimidine (FP) dose individualization based on pretreatment uracil levels: Safety and pharmacokinetic (PK) analysis from the Alpe2U study
err2022-09-01
err1
errOAAI
errDe With, M.; Knikman, J.; Baars, A.; Creemers, G-J. M.; Droogendijk, H. J.; Fiets, E.; Imholz, A. L. T.; Valkenburg-van Iersel, L. B. J.; Jeurissen, F. J. F.; Mandigers, C. M. P. W.; Van Schaik, R. H. N.; van den Bosch, B. J. C.; Rosing, H.; Beijnen, J. H.; Swen, J. J.; Gelderblom, H.; Schellens, J. H. M.; Mathijssen, R. H.; Guchelaar, H-J.; Cats, A.
errShare
errSave
Dihydropyrimidine Dehydrogenase Phenotyping Using Pretreatment Uracil: A Note of Caution Based on a Large Prospective Clinical Study
err2022-05-04
err40
errOAAI
errde With, Mirjam; Knikman, Jonathan; de Man, Femke M.; Lunenburg, Carin A. T. C.; Henricks, Linda M.; van Kuilenburg, Andre B. P.; Maring, Jan G.; van Staveren, Maurice C.; de Vries, Niels; Rosing, Hilde; Beijnen, Jos H.; Pluim, Dick; Modak, Anil; Imholz, Alex L. T.; van Schaik, Ron H. N.; Schellens, Jan H. M.; Gelderblom, Hans; Cats, Annemieke; Guchelaar, Henk-Jan; Mathijssen, Ron H. J.; Swen, Jesse J.; Meulendijks, Didier
errShare
errSave
A Phase I dose-escalation study of two cycles carboplatinol-aparib followed by olaparib monotherapy in patients with advanced cancer
err2021-02-27
err3
errOAAI
errGeenen, Jill J. J.; Dackus, Gwen M. H. E.; Schouten, Philip C.; Pluim, Dick; Marchetti, Serena; Sonke, Gabe S.; Jozwiak, Katarzyna; Huitema, Alwin D. R.; Beijnen, Jos H.; Schellens, Jan H. M.; Linn, Sabine C.
errShare
errSave
Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy
errEJSO
IF2.9
err2021-02-01
err4
PREAI
errKoemans, W. J.; van der Kaaij, R. T.; Wassenaar, E. C. E.; Grootscholten, C.; Boot, H.; Boerma, D.; Los, M.; Imhof, O.; Schellens, J. H. M.; Rosing, H.; Huitema, A. D. R.; van Sandick, J. W.
errShare
errSave
A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours
err2020-11-24
err74
errOAAI
errvan Bussel, Mark T. J.; Awada, Ahmad; de Jonge, Maja J. A.; Mau-Sorensen, Morten; Nielsen, Dorte; Schoffski, Patrick; Verheul, Henk M. W.; Sarholz, Barbara; Berghoff, Karin; El Bawab, Samer; Kuipers, Mirjam; Damstrup, Lars; Diaz-Padilla, Ivan; Schellens, Jan H. M.
errShare
errSave
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial
err2020-11-19
err10
PREAI
errLebbe, Celeste; Italiano, Antoine; Houede, Nadine; Awada, Ahmad; Aftimos, Philippe; Lesimple, Thierry; Dinulescu, Monica; Schellens, Jan H. M.; Leijen, Suzanne; Rottey, Sylvie; Kruse, Vibeke; Kefford, Richard; Raymond, Eric; Faivre, Sandrine; Pages, Celine; Gomez-Roca, Carlos; Schueler, Armin; Goodstal, Samantha; Massimini, Giorgio; Delord, Jean-Pierre
errShare
errSave
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors
err2020-11-10
err7
PREAI
errDelord, Jean-Pierre; Italiano, Antoine; Awada, Ahmad; Aftimos, Philippe; Houede, Nadine; Lebbe, Celeste; Pages, Celine; Lesimple, Thierry; Dinulescu, Monica; Schellens, Jan H. M.; Leijen, Suzanne; Rottey, Sylvie; Kruse, Vibeke; Kefford, Richard; Faivre, Sandrine; Gomez-Roca, Carlos; Scheuler, Armin; Massimini, Giorgio; Raymond, Eric
errShare
errSave
Breakthrough therapy-designated oncology drugs: are they rightfully criticized?
err2020-09-01
err5
PREAI
errMulder, Jorn; Pasmooij, Anna M. G.; Stoyanova-Beninska, Violeta V.; Schellens, Jan H. M.
errShare
errSave
SYD985 synergy with PARP inhibitors (PARPi) in human tumor cell lines and patient-derived xenografts (PDXs)
err2020-08-15
err1
PREAI
errDokter, Wim H.; Dijcks, Fred A.; Groothuis, Patrick G.; Mattaar, Ellen; Loosveld, Eline; Jacobs, Danielle; van der Vleuten, Monique; Schellens, Jan H.; van der Lee, Miranda
errShare
errSave
Phase I pharmacological study of continuous chronomodulated capecitabine treatment
err2020-05-07
err13
errOAAI
errRoosendaal, Jeroen; Jacobs, Bart A. W.; Pluim, Dick; Rosing, Hilde; de Vries, Niels; van Werkhoven, Erik; Nuijen, Bastiaan; Beijnen, Jos H.; Huitema, Alwin D. R.; Schellens, Jan H. M.; Marchetti, Serena
errShare
errSave
Pembrolizumab for the treatment of programmed death-ligand 1-positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study
errCANCER
IF5.1
err2020-04-22
err102
errOAAI
errMehnert, Janice M.; Bergsland, Emily; O'Neil, Bert H.; Santoro, Armando; Schellens, Jan H. M.; Cohen, Roger B.; Doi, Toshihiko; Ott, Patrick A.; Pishvaian, Michael J.; Puzanov, Igor; Aung, Kyaw L.; Hsu, Chiun; Le Tourneau, Christophe; Hollebecque, Antoine; Elez, Elena; Tamura, Kenji; Gould, Marlena; Yang, Ping; Stein, Karen; Piha-Paul, Sarina A.
errShare
errSave
Quantification of the pharmacokinetic-toxicodynamic relationship of oral docetaxel co-administered with ritonavir
err2020-04-19
err1
PREAI
errYu, Huixin; Janssen, Julie M.; de Weger, Vincent A.; Nuijen, Bastiaan; Stuurman, Rik E.; Marchetti, Serena; Schellens, Jan H. M.; Beijnen, Jos H.; Dorlo, Thomas P. C.; Huitema, Alwin D. R.
errShare
errSave
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairment
err2020-04-05
err15
errOAAI
errRolfo, Christian; Isambert, Nicolas; Italiano, Antoine; Molife, L. Rhoda; Schellens, Jan Hm; Blay, Jean-Yves; Decaens, Thomas; Kristeleit, Rebecca; Rosmorduc, Olivier; Demlova, Regina; Lee, Myung-Ah; Ravaud, Alain; Kopeckova, Katerina; Learoyd, Maria; Bannister, Wendy; Locker, Gershon; de Vos-Geelen, Judith
errShare
errSave